| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Chief Legal &Admin Officer | Chief Legal And Admin Officer
1 company
Robertson Jenny serves as a Chief Legal Officer at LXEO. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $334K at current prices.
Historically, Robertson Jenny's trades have earned a below-average insider score of 32/100 across 5 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -48.8%.
The biggest single holding is LXEO (~$334K) as Chief Legal Officer. The recent filings there lean toward selling, a net 7,239 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Legal Officer | Sell | 549 | $9.27 | $5,089.23 | -0.8% | -31.6% | - | |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Legal Officer | Sell | 3,526 | $8.94 | $31,529.85 | -2.5% | -21.7% | - | |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Legal Officer | Sell | 542 | $4.67 | $2,530.06 | -0.9% | +92.7% | - | |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Legal Officer | Sell | 521 | $2.77 | $1,445.25 | -0.8% | +47.8% | +57.1% | |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Legal Officer | Sell | 2,101 | $4.41 | $9,271.71 | -3.5% | -20.9% | +40.6% |